Related Experiment Video
Updated: May 22, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Summary
This study reassessed 263 tumors, identifying pleomorphic fibrosarcoma in 5% of cases. These sarcomas present as painless masses with significant recurrence and metastasis rates, similar to malignant fibrous histiocytoma.
Area of Science:
- Oncology
- Pathology
- Surgical Pathology
Background:
- Malignant fibrous histiocytoma (MFH) and undifferentiated pleomorphic sarcoma (UPS) are challenging diagnoses.
- Reassessment of these tumor types is crucial for accurate classification and treatment.
Purpose of the Study:
- To re-evaluate a cohort of MFH and UPS tumors using comprehensive methods.
- To identify potential distinct entities within this group, specifically pleomorphic fibrosarcoma.
Main Methods:
- Morphological, immunohistochemical, and ultrastructural analyses were performed on 263 tumors.
- Clinical data, including patient history, tumor location, and follow-up information, were collected.
Main Results:
- Nineteen patients (5%) were diagnosed with pleomorphic fibrosarcoma.
- Tumors were predominantly located in extremities and trunk, presenting as painless masses.
- Recurrence (24%) and metastasis (32%) rates were significant; survival rates were similar to MFH.
Conclusions:
- Pleomorphic fibrosarcoma is a distinct entity within the MFH/UPS spectrum.
- These tumors share clinical and radiographic features with MFH, necessitating careful pathological evaluation.
- The ultrastructural findings highlight the fibroblast/myofibroblast origin with limited differentiation.
